- Home
- FRGT vs QLGN Comparison
FRGT vs QLGN Comparison
Compare FRGT & QLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRGT
- QLGN
- Stock Information
- Founded
- FRGT 2015
- QLGN 1996
- Country
- FRGT United States
- QLGN United States
- Employees
- FRGT N/A
- QLGN N/A
- Industry
- FRGT Professional Services
- QLGN Biotechnology: Pharmaceutical Preparations
- Sector
- FRGT Consumer Discretionary
- QLGN Health Care
- Exchange
- FRGT Nasdaq
- QLGN Nasdaq
- Market Cap
- FRGT 2.9M
- QLGN 3.2M
- IPO Year
- FRGT N/A
- QLGN N/A
- Fundamental
- Price
- FRGT $1.36
- QLGN $4.07
- Analyst Decision
- FRGT
- QLGN
- Analyst Count
- FRGT 0
- QLGN 0
- Target Price
- FRGT N/A
- QLGN N/A
- AVG Volume (30 Days)
- FRGT 204.8K
- QLGN 20.7K
- Earning Date
- FRGT 01-28-2025
- QLGN 11-14-2024
- Dividend Yield
- FRGT N/A
- QLGN N/A
- EPS Growth
- FRGT N/A
- QLGN N/A
- EPS
- FRGT N/A
- QLGN N/A
- Revenue
- FRGT $17,567,033.00
- QLGN N/A
- Revenue This Year
- FRGT $144.53
- QLGN N/A
- Revenue Next Year
- FRGT $55.01
- QLGN N/A
- P/E Ratio
- FRGT N/A
- QLGN N/A
- Revenue Growth
- FRGT N/A
- QLGN N/A
- 52 Week Low
- FRGT $1.25
- QLGN $3.34
- 52 Week High
- FRGT $80.75
- QLGN $29.45
- Technical
- Relative Strength Index (RSI)
- FRGT 38.55
- QLGN 45.00
- Support Level
- FRGT $1.25
- QLGN $3.95
- Resistance Level
- FRGT $1.47
- QLGN $4.21
- Average True Range (ATR)
- FRGT 0.20
- QLGN 0.27
- MACD
- FRGT -0.07
- QLGN 0.00
- Stochastic Oscillator
- FRGT 10.09
- QLGN 22.08
About FRGT Freight Technologies Inc.
Freight Technologies Inc is a technology company developing solutions to optimize and automate the supply chain process. Along with its subsidiary, Freight App, Inc, the group is focused on making shipping transparent and efficient. Fr8App provides carriers with increased growth opportunities and shippers with flexibility, visibility, and simplicity for the once-complex process of international over-the-road (OTR) shipping. The company uses its proprietary technology platform to connect carriers and shippers and significantly improve matching and operation efficiency via technologies such as live pricing and real-time tracking, digital freight marketplace, broker, transportation management, fleet management, and committed capacity solutions.
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.